Abbott Laboratories (NYSE:ABT) reported its Q4 earnings results on Wednesday, January 26, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Abbott Laboratories beat estimated earnings by 9.09%, reporting an EPS of $1.32 versus an estimate of $1.21, which did not surprise analysts.
Revenue was up $767.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.46, which was followed by a 1.41% increase in the share price the next day.
Here's a look at Abbott Laboratories's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.94 | 1.02 | 1.27 | 1.35 |
| EPS Actual | 1.40 | 1.17 | 1.32 | 1.45 |
| Revenue Estimate | 9.54B | 9.69B | 10.69B | 9.94B |
| Revenue Actual | 10.93B | 10.22B | 10.46B | 10.70B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
